Steris Stock News

Shares of STERIS plc (NYSE:STE) hit a new 52-week high during trading on Tuesday . The company traded as high as $237.36 and last traded at $236.73, with a volume of 16804 shares traded. The stock had previously closed at $232.38. A number of equities analysts have recently issued reports on STE shares. KeyCorp increased […]

Investors are optimistic about STERIS (STE) owing to its strong fiscal second-quarter results and bullish 2022 outlook.

Ortho Regenerative Technologies (OTCMKTS:ORTIF) and STERIS (NYSE:STE) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, risk, institutional ownership and earnings. Insider and Institutional Ownership 90.0% of STERIS shares are held by institutional investors. 1.1% of STERIS []

Colony Group LLC reduced its position in shares of STERIS plc (NYSE:STE) by 27.0% in the second quarter, HoldingsChannel.com reports. The firm owned 1,595 shares of the medical equipment providers stock after selling 589 shares during the period. Colony Group LLCs holdings in STERIS were worth $329,000 at the end of the most recent quarter. []

Colonoscopy Devices Market: Overview The colonoscopy devices market is growing on the back of increasing emphasis to develop technologically advanced products and a growing number of production of colonoscopy devices. Further, the presence of a technologically developed healthcare system and growing

STERIS plc (Ireland) found using ticker (STE) now have 5 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 270 and 250 with a mean TP of 256. Given that the stocks previous close was at 231.52 this indicates there is a potential upside of 10.6%. The day 50 moving average is 223.65 and the 200 moving average now moves to 212.01. The market capitalisation for the company is $23,160m. Company Website: /> [stock_market_widget type="chart" symbol="STE" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

STERIS (NYSE:STE) and Ortho Regenerative Technologies (OTCMKTS:ORTIF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability. Insider and Institutional Ownership 90.0% of STERIS shares are held by institutional investors. 1.1% of STERIS []

Solid growth across all three reporting segments drove STERIS' (STE) second-quarter fiscal 2022 revenues.

STERIS plc (STE) CEO Dan Carestio on Q2 2022 results - Earnings Call Transcript

With the pandemic raging on, testing, vaccine and therapeutic makers are witnessing huge market adoption of their COVID-related support products in Q3.

Strong gains from the recent Cantel Medical buyout as well as the addition of a new Dental arm are expected to have contributed STERIS' (STE) Q2 performance.

Dublin, Ireland, Oct. 20, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 second quar

Investors are optimistic about STERIS (STE) owing to elevated consumer demand and rebound in procedure volumes and raised 2022 outlook.

Steris (STE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Steris (STE) reported earnings 30 days ago. What's next for the stock?